Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan
2013
Idiopathic pulmonary fibrosis (IPF) is a life-threatening, progressive disease with no approved therapy. Endothelin-1 is believed to be involved in its pathogenesis. This trial aimed to determine t...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
4
Citations
NaN
KQI